Clinical Trial Update: Personalized Immunotherapy in Adults With Upper Gastrointestinal Tract Cancers [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update indicates a Phase 1/2 personalized immunotherapy study in adults with upper gastrointestinal tract cancers has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer

Snippet

Sponsor: University of California, San Diego | Conditions: Cancer of Gastrointestinal Tract | Phase 1, Phase 2 | Status: WITHDRAWN